Creatinine kinase isoenzyme-MB: A simple prognostic biomarker in patients with pulmonary embolism treated with thrombolytic therapy

Bozbay M., Uyarel H., Avsar S., Oz A., Keskin M., Tanik V. O., ...Daha Fazla

JOURNAL OF CRITICAL CARE, cilt.30, sa.6, ss.1179-1183, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 30 Sayı: 6
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1016/j.jcrc.2015.07.014
  • Dergi Adı: JOURNAL OF CRITICAL CARE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1179-1183
  • Bezmiâlem Vakıf Üniversitesi Adresli: Evet

Özet

Background: Creatinine kinase isoenzyme-MB(CK-MB) is a biomarker for detecting myocardial injury. The aim of this study was to evaluate the association between admission CK-MB levels and in-hospital and long-term clinical outcomes in pulmonary embolism(PE) patients treated with thrombolytic tissue-plasminogen activator.